HomeNGM • NASDAQ
add
NGM Biopharmaceuticals Inc
Previous close
$1.54
Year range
$0.60 - $4.69
Market cap
128.53M USD
Avg Volume
1.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 165.00K | -99.09% |
Operating expense | 7.94M | -18.63% |
Net income | -27.67M | 24.06% |
Net profit margin | -16.77K | -8,267.70% |
Earnings per share | -0.33 | 26.67% |
EBITDA | -29.14M | 22.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 144.18M | -46.89% |
Total assets | 168.87M | -45.07% |
Total liabilities | 20.23M | -57.71% |
Total equity | 148.64M | — |
Shares outstanding | 83.46M | — |
Price to book | 0.86 | — |
Return on assets | -41.08% | — |
Return on capital | -46.37% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -27.67M | 24.06% |
Cash from operations | -22.96M | 24.47% |
Cash from investing | 27.19M | 1,510.90% |
Cash from financing | 111.00K | -84.65% |
Net change in cash | 4.34M | 115.50% |
Free cash flow | -14.06M | 20.28% |
About
Founded
2007
Headquarters
Website
Employees
138